These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12053057)

  • 1. Nonselective Beta-adrenergic blockade augments fasting hyperkalemia in hemodialysis patients.
    Nowicki M; Miszczak-Kuban J
    Nephron; 2002 Jun; 91(2):222-7. PubMed ID: 12053057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol does not modulate moderate exercise-induced hyperkalemia in hemodialysis patients.
    Nowicki M; Szewczyk-Seifert G; Klimek D; Kokot F
    Clin Nephrol; 2002 May; 57(5):352-8. PubMed ID: 12036194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the alpha-1-adrenergic receptor blocker doxazosin on exercise-induced hyperkalemia in hemodialysis patients.
    Nowicki M; Waluś T; Kokot F
    Kidney Blood Press Res; 2002; 25(1):55-60. PubMed ID: 11834878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Movilli E; Camerini C; Gaggia P; Zubani R; Cancarini G
    Am J Nephrol; 2018; 48(2):79-86. PubMed ID: 30071530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.
    Blumberg A; Weidmann P; Shaw S; Gnädinger M
    Am J Med; 1988 Oct; 85(4):507-12. PubMed ID: 3052050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia.
    Allon M; Takeshian A; Shanklin N
    Kidney Int; 1993 Jan; 43(1):212-7. PubMed ID: 8433561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.
    Kim HJ
    Nephron; 1996; 72(3):476-82. PubMed ID: 8852501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
    Montoliu J; Lens XM; Revert L
    Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.
    Khosla N; Kalaitzidis R; Bakris GL
    Am J Nephrol; 2009; 30(5):418-24. PubMed ID: 19738369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients.
    Farese S; Kruse A; Pasch A; Dick B; Frey BM; Uehlinger DE; Frey FJ
    Kidney Int; 2009 Oct; 76(8):877-84. PubMed ID: 19641483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis.
    Furuya R; Kumagai H; Sakao T; Maruyama Y; Hishida A
    Nephron; 2002; 92(3):576-81. PubMed ID: 12372940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
    Kaisar MO; Wiggins KJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Mudge DW; Bofinger A; Petrie JJ; Johnson DW
    Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease.
    Allon M; Dansby L; Shanklin N
    Am J Med; 1993 May; 94(5):475-482. PubMed ID: 8498392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperkalemia in hypertensive patients undergoing regular hemodialysis during enalapril and fosinopril therapy].
    Dimković N; Djordjević T; Popović J; Dimković S; Tirmenstajn-Janković B; Zivanović M; Bobanović-Hasković J
    Srp Arh Celok Lek; 2006; 134(1-2):44-8. PubMed ID: 16850577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of serum potassium during fasting in patients with end-stage renal disease.
    Gifford JD; Rutsky EA; Kirk KA; McDaniel HG
    Kidney Int; 1989 Jan; 35(1):90-4. PubMed ID: 2651754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U; Blasini R
    Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.
    Allon M; Shanklin N
    Am J Kidney Dis; 1996 Oct; 28(4):508-14. PubMed ID: 8840939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.
    Fishbane S; Ford M; Fukagawa M; McCafferty K; Rastogi A; Spinowitz B; Staroselskiy K; Vishnevskiy K; Lisovskaja V; Al-Shurbaji A; Guzman N; Bhandari S
    J Am Soc Nephrol; 2019 Sep; 30(9):1723-1733. PubMed ID: 31201218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-threatening hyperkalemia after intravenous labetolol injection for hypertensive emergency in a hemodialysis patient.
    Hamad A; Salameh M; Zihlif M; Feinfeld DA; Carvounis CP
    Am J Nephrol; 2001; 21(3):241-4. PubMed ID: 11423696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone.
    Arrizabalaga P; Montoliu J; Martinez Vea A; Andreu L; López Pedret J; Revert L
    Proc Eur Dial Transplant Assoc; 1983; 20():572-6. PubMed ID: 6318223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.